Back to search

Quantitative Determination of Nuclear and Cytoplasmic Epidermal Growth Factor Receptor Expression in Oropharyngeal Squamous Cell Cancer by Using Automated Quantitative Analysis

Data up to Jan 2025

Published2005
Citations261
References22

Total Citations Per Year

Abstract

References (22)

Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer

2004 • 4,992 citations

Cancer Statistics, 2004

2004 • 4,026 citations

Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor Receptor

2004 • 1,709 citations

RECEPTORS FOR EPIDERMAL GROWTH FACTOR AND OTHER POLYPEPTIDE MITOGENS

1987 • 1,274 citations

Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.

2002 • 1,173 citations

Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry

2005 • 1,081 citations

Nuclear localization of EGF receptor and its potential new role as a transcription factor

2001 • 1,049 citations

Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer.

1993 • 837 citations

Phase I Safety, Pharmacokinetic, and Pharmacodynamic Trial of ZD1839, a Selective Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Five Selected Solid Tumor Types

2002 • 828 citations

Automated subcellular localization and quantification of protein expression in tissue microarrays

2002 • 764 citations

Phase II Trial of ZD1839 in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

2003 • 616 citations

EPIDERMAL-GROWTH-FACTOR RECEPTORS AND OESTROGEN RECEPTORS IN HUMAN BREAST CANCER

1985 • 496 citations

Cetuximab prolongs survival in patients with locoregionally advanced squamous cell carcinoma of head and neck: A phase III study of high dose radiation therapy with or without cetuximab

2004 • 208 citations

Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome.

2003 • 204 citations

Nuclear localization and possible functions of receptor tyrosine kinases

2003 • 169 citations

Prognostic Significance of p16 Protein Levels in Oropharyngeal Squamous Cell Cancer

2004 • 153 citations

Quantitative Determination of Expression of the Prostate Cancer Protein α-Methylacyl-CoA Racemase Using Automated Quantitative Analysis (AQUA)

2004 • 150 citations

Treatment of Locally Advanced Head and Neck Cancer: Historical and Critical Review

2002 • 129 citations

Enhanced Nectin-1 Expression and Herpes Oncolytic Sensitivity in Highly Migratory and Invasive Carcinoma

2005 • 113 citations

Activity of cetuximab in patients with colorectal cancer refractory to both irinotecan and oxaliplatin

2004 • 95 citations

Cyclin D1 Is a Valuable Prognostic Marker in Oropharyngeal Squamous Cell Carcinoma

2005 • 72 citations

Molecular marker expression in oral and oropharyngeal squamous cell carcinoma.

2001 • 61 citations

Cited By (0)

Loading...
Quantitative Determination of Nuclear and Cytoplasmic Epidermal Growth Factor Receptor… (2005) – Clinical Cancer Research | Metascience Observatory Explorer